European Journal of Cancer
Volume 37, Issue 3 , Pages 364-368 , February 2001

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

  • M. De Lena

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +390-80-555-5471; fax: +390-80-555-5471
  • ,
  • V. Lorusso

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
  • ,
  • A. Latorre

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
  • ,
  • G. Fanizza

      Affiliations

    • Gynaecological Department, Oncology Institute of Bari, Via Amendolo 209, 70126 Bari, Italy
  • ,
  • G. Gargano

      Affiliations

    • Gynaecological Department, Oncology Institute of Bari, Via Amendolo 209, 70126 Bari, Italy
  • ,
  • L. Caporusso

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
  • ,
  • M. Guida

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
  • ,
  • A. Catino

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
  • ,
  • E. Crucitta

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
  • ,
  • D. Sambiasi

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy
  • ,
  • A. Mazzei

      Affiliations

    • Medical-Oncology Department, Oncology Institute of Bari, Via Amendola 209, 70126 Bari, Italy

Received 29 March 2000 ,Revised 1 August 2000 ,Accepted 8 November 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(00)00400-7

European Journal of Cancer
Volume 37, Issue 3 , Pages 364-368 , February 2001